These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26032265)

  • 61. FcγRIIa and FcγRIIIb polymorphisms and associations with clinical manifestations in systemic lupus erythematosus patients.
    Vigato-Ferreira IC; Toller-Kawahisa JE; Pancoto JA; Mendes-Junior CT; Martinez EZ; Donadi EA; Louzada-Júnior P; Del Lama JE; Marzocchi-Machado CM
    Autoimmunity; 2014 Nov; 47(7):451-8. PubMed ID: 24896836
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Understanding the Genomic Structure of Copy-Number Variation of the Low-Affinity Fcγ Receptor Region Allows Confirmation of the Association of FCGR3B Deletion with Rheumatoid Arthritis.
    Rahbari R; Zuccherato LW; Tischler G; Chihota B; Ozturk H; Saleem S; Tarazona-Santos E; Machado LR; Hollox EJ
    Hum Mutat; 2017 Apr; 38(4):390-399. PubMed ID: 27995740
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis.
    Wijngaarden S; van de Winkel JG; Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2004 Dec; 50(12):3878-87. PubMed ID: 15593228
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity.
    Fanciulli M; Norsworthy PJ; Petretto E; Dong R; Harper L; Kamesh L; Heward JM; Gough SC; de Smith A; Blakemore AI; Froguel P; Owen CJ; Pearce SH; Teixeira L; Guillevin L; Graham DS; Pusey CD; Cook HT; Vyse TJ; Aitman TJ
    Nat Genet; 2007 Jun; 39(6):721-3. PubMed ID: 17529978
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic variations in low-to-medium-affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort.
    Kløve-Mogensen K; Steffensen R; Masmas TN; Glenthøj A; Jensen CF; Haunstrup TM; Ratcliffe P; Höglund P; Hasle H; Nielsen KR
    Int J Immunogenet; 2023 Apr; 50(2):65-74. PubMed ID: 36754570
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease.
    van der Pol WL; Huizinga TW; Vidarsson G; van der Linden MW; Jansen MD; Keijsers V; de Straat FG; Westerdaal NA; de Winkel JG; Westendorp RG
    J Infect Dis; 2001 Dec; 184(12):1548-55. PubMed ID: 11740730
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Correlating multiallelic copy number polymorphisms with disease susceptibility.
    Cantsilieris S; White SJ
    Hum Mutat; 2013 Jan; 34(1):1-13. PubMed ID: 22837109
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Spectrum of autoimmune bullous diseases in Iran: a 10-year review.
    Daneshpazhooh M; Chams-Davatchi C; Payandemehr P; Nassiri S; Valikhani M; Safai-Naraghi Z
    Int J Dermatol; 2012 Jan; 51(1):35-41. PubMed ID: 22182376
    [TBL] [Abstract][Full Text] [Related]  

  • 70. FcγRIIB and autoimmunity.
    Espéli M; Smith KG; Clatworthy MR
    Immunol Rev; 2016 Jan; 269(1):194-211. PubMed ID: 26683154
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A functional variant of Fcgamma receptor IIIA is associated with rheumatoid arthritis in individuals who are positive for anti-glucose-6-phosphate isomerase antibodies.
    Matsumoto I; Zhang H; Muraki Y; Hayashi T; Yasukochi T; Kori Y; Goto D; Ito S; Tsutsumi A; Sumida T
    Arthritis Res Ther; 2005; 7(6):R1183-8. PubMed ID: 16277670
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The interleukin-1 and Fcgamma receptor gene polymorphisms in Japanese patients with rheumatoid arthritis and periodontitis.
    Kobayashi T; Ito S; Kuroda T; Yamamoto K; Sugita N; Narita I; Sumida T; Gejyo F; Yoshie H
    J Periodontol; 2007 Dec; 78(12):2311-8. PubMed ID: 18052703
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hardy-Weinberg equilibrium revisited for inferences on genotypes featuring allele and copy-number variations.
    Recke A; Recke KG; Ibrahim S; Möller S; Vonthein R
    Sci Rep; 2015 Mar; 5():9066. PubMed ID: 25765626
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mechanisms of blister induction by autoantibodies.
    Sitaru C; Zillikens D
    Exp Dermatol; 2005 Dec; 14(12):861-75. PubMed ID: 16274453
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
    Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
    Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The IgG Fc receptor family.
    Gessner JE; Heiken H; Tamm A; Schmidt RE
    Ann Hematol; 1998 Jun; 76(6):231-48. PubMed ID: 9692811
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Investigation of candidate gene copy number identifies FCGR3B as a potential biomarker for rheumatoid arthritis.
    Ben Kilani MS; Cornélis F; Olaso R; Chaudru V; Petit-Teixeira E
    Clin Exp Rheumatol; 2019; 37(6):923-928. PubMed ID: 30873943
    [TBL] [Abstract][Full Text] [Related]  

  • 80. STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation.
    Braun A; Gessner JE; Varga-Szabo D; Syed SN; Konrad S; Stegner D; Vögtle T; Schmidt RE; Nieswandt B
    Blood; 2009 Jan; 113(5):1097-104. PubMed ID: 18941110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.